Security key
45256X103
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 149,650,186
- Total 13F value
- $368,148,509
- Share change
- +25,585,561
- Put/Call ratio
- 129%
- SEC-reported price per share
- $2.46
- Number of holders
- 258
- Value change
- +$61,432,781
- Number of buys
- 136
- Number of sells
- 80
- Shares outstanding
- 1,124,549,707
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
258
Top holders
10
IBRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
ImmunityBio, Inc. SEC filings
ImmunityBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45256X103
Recent filing periods:
Ownership snapshot
Top reported holders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
Lead comparable stake: 1.9%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 1.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
1.9%
BlackRock, Inc.
1.6%
BANK OF AMERICA CORP /DE/
0.78%
ARMISTICE CAPITAL, LLC
0.69%
JANE STREET GROUP, LLC
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$57,597,690
21,817,307 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
1.6%
|
$46,905,442
17,767,213 shares
|
— | 30 Jun 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.78%
|
$23,116,323
8,756,183 shares
|
— | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.69%
|
$20,496,960
7,764,000 shares
|
— | 30 Jun 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.69%
|
$20,376,220
7,718,265 shares
|
— | 30 Jun 2025 |
| STATE STREET CORP |
13F
Company
|
0.68%
|
$20,105,094
7,615,566 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
258
Shares
149,650,186
Rows available
258
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
236
Q3 2025 holders
258
Holder diff
22
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend